Patient Retention for Phase IIB OAB Drug Across Six Continents

February 9, 2018

Challenge

Retain 700 subjects who completed the first part of the study into a 52-week extension study across six continents.

Solution

ThreeWire developed comprehensive patient retention materials for distribution among global sites. Materials included both site-focused items (e.g., Tips and Techniques for Study Coordinators, Participant Contact Forms and Logs ) and patient-focused items (e.g., study guides, newsletters, greeting cards, certificates of appreciation).

Results

Completed creative development of materials in 13 languages within a month of project award. IRB approved materials were sent electronically to sponsor for printing and distribution.

Previous Flipbook
Study Marketing for Phase III Pediatric Influenza Vaccine - North America, Europe & Asia
Study Marketing for Phase III Pediatric Influenza Vaccine - North America, Europe & Asia

ThreeWire was called upon to provide study branding and creative services to develop study support material...

Next Flipbook
Peripheral Neuropathy in Post Stroke Patients
Peripheral Neuropathy in Post Stroke Patients

Challenge Meet time-sensitive enrollment goal of 496 patients in order to extend labeling for client’s FDA-...